Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New study signals hope for treatment of rare neurodegenerative disease

New study signals hope for treatment of rare neurodegenerative disease

Congress examines health care payment issues and high costs

Congress examines health care payment issues and high costs

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

Spanish researchers confirm genetic risk factor for osteoporosis and bone fractures

N.J. Democrats fail to restore funds to family-planning centers; Penn. reports record number eligible for Medicaid; N.Y. report suggests overhauling Medicaid system

N.J. Democrats fail to restore funds to family-planning centers; Penn. reports record number eligible for Medicaid; N.Y. report suggests overhauling Medicaid system

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

ARRA's legacies may solve challenges related to health, energy and environment

ARRA's legacies may solve challenges related to health, energy and environment

Elder mediation emerges as tool to help families make decisions about aging parents

Elder mediation emerges as tool to help families make decisions about aging parents

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

QR Pharma and MUSC receive $220,000 SBIR grant to study Posiphen in AD transgenic mice

QR Pharma and MUSC receive $220,000 SBIR grant to study Posiphen in AD transgenic mice

ADI releases World Alzheimer Report 2010

ADI releases World Alzheimer Report 2010

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

Ginkgo-special extract improves mental performance of dementia patients

Ginkgo-special extract improves mental performance of dementia patients

Global dementia costs hit $604 billion: World Alzheimer Report 2010

Global dementia costs hit $604 billion: World Alzheimer Report 2010

Alzheimer's disaster is no longer 'emerging'

Alzheimer's disaster is no longer 'emerging'

Global action needed to address 'most significant health crisis of the 21st century'

Global action needed to address 'most significant health crisis of the 21st century'

Arrayit installs microarray platform at NIH

Arrayit installs microarray platform at NIH

Pollution increases risk for sudden cardiac arrest

Pollution increases risk for sudden cardiac arrest

Intravenous aspirin safe, effective option for severe headache or migraine

Intravenous aspirin safe, effective option for severe headache or migraine

Gene deletion may make you smarter: Study

Gene deletion may make you smarter: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.